Viewing stories from February, 2014
Starpharma to present to US institutional investors
Starpharma will participate later today in the ASX Spotlight New York event. Starpharma is one of 15 ASX listed companies to be featured at the event, which is held annually to showcase emerging Australian companies before US institutional investors.
Starpharma Interim Report and Half-year Financial Results
Starpharma today released its interim report and financial results for the half-year ended 31 December 2013.
Financial Summary
- Reported loss of $5.6M (Dec 2012: $1.8M)
- R&D tax incentives of $2.6M reported in the half-year (Dec 2012: $6.8M)
- Cash position at 31 December 2013 of $27.8M
- R&D tax incentive receivables at 31 December 2013 of $7.3M